Sanofi investing S$638 million for the production of vaccine in Singapore Photo by: Lionel Allorge/Wikimedia Commons (CC BY-SA 2.0) Wednesday, April 14, 2021 9:26 AM UTC Related Stories Sanofi confirmed on Monday, April 12, that it is investing in Singapore for its vaccine production in the region. The French drugmaker is spending S$637 million or around €400 million that will be given out in over five years. Sanofi’s new facility will be set up at SG’s Tuas Biomedical Park, and it will mainly be for the production of vaccines to be supplied in Asia. It was said that with the investment, the company is not just aiming to produce a massive amount of vaccines but to be able to quickly respond to pandemic risks that can happen in the future.